StockNews.com began coverage on shares of Pulmatrix (NASDAQ:PULM – Free Report) in a research report released on Saturday. The brokerage issued a hold rating on the biotechnology company’s stock. Pulmatrix Price Performance NASDAQ:PULM opened at $1.94 on Friday. The business’s 50-day moving average is $1.87 and its two-hundred day moving average is $1.88. Pulmatrix has […]
Pulmatrix : Announces Peer-Reviewed Publication of Clinical Results for its Orally Inhaled DHE for Acute Migraine (PUR3100) - Form 8-K
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Pulmatrix Announces Peer-Reviewed Publication of Clinical Results for its Orally Inhaled DHE for Acute Migraine (PUR3100)
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.